Psychedelic Business Spotlight: November 19
This week in psychedelic business news: Companies partner on new dosage method; MindMed investigates LSD microdosing; Health Canada allows a psilocybin production campus.
MindMed
Psychedelic Business Spotlight: October 29
This week in psychedelic business news: MindMed’s MDMA research pipeline to treat Autism Spectrum Disorder; Cybin EMBARKs; Awakn and MindCure partner to heal alcoholism.
Why Psychedelic Stocks Have Crashed in the Last 3 Months
Our resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay off big time.
MindMed, Forian Developing Personalized Psychiatry for Anxiety Disorders
MindMed is currently conducting several clinical trials using psychedelic-inspired medicines, including studying LSD experiential therapy for anxiety, LSD microdosing for adult ADHD, and 18-MC for opioid withdrawal.
Psychedelic Business Spotlight: July 30, 2021
This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.
Psychedelic Business Spotlight: July 16, 2021
This week in psychedelic business news: A generous donation to advance MDMA research, psilocybin for end-of-life anxiety, and provisional patents filed for synthesizing ibogaine.
End of content
End of content